Cairo – Mubasher: Kahira Pharmaceuticals posted an increase of 19% in net profits for the first nine months of 2015.
The drug firm reported net profits of EGP 24.9 million for this nine-month period of 2015, compared with EGP 21 million for the same period of the previous year.
The company’s top line inched down 1.2% to EGP 102.9 million in the first nine months of 2015, compared with EGP 104.1 million for the same period a year earlier.
